|
|
||||||||
Institute of Pharmacology and Therapeutics, Faculty of Medicine, 4200-319 Porto, Portugal
We examined the nature and regulation of the inward L-3,4-dihydroxyphenylalanine (L-DOPA) transporter in rat capillary cerebral endothelial (RBE4) cells, type 1 astrocytes (DI TNC1), and Neuro-2a neuroblastoma cells. In all three cell types, the inward transfer of L-DOPA was largely promoted through the 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid-sensitive and sodium-independent L-type amino acid transporter. Only in DI TNC1 cells was the effect of maneuvers that increase intracellular cAMP levels accompanied by increases in L-DOPA uptake. Also, only in DI TNC1 cells was the effect of the guanylyl cyclase inhibitor LY-83583 accompanied by a 65% increase in L-DOPA accumulation, whereas the nitric oxide donor sodium nitroprusside produced a 25% decrease in L-DOPA accumulation. In all three cell types, the Ca2+/calmodulin inhibitors calmidazolium and trifluoperazine inhibited L-DOPA uptake in a noncompetitive manner. Thapsigargin (1 and 3 µM) and A-23187 (1 and 3 µM) failed to alter L-DOPA accumulation in RBE4 and Neuro-2a cells but markedly increased L-DOPA uptake in DI TNC1 cells. We concluded that L-DOPA in RBE4, DI TNC1, and Neuro-2a cells is transported through the L-type amino acid transporter and appears to be under the control of Ca2+/calmodulin-mediated pathways. Astrocytes, however, are endowed with other processes that appear to regulate the accumulation of L-DOPA, responding positively to increases in intracellular Ca2+ and cAMP and to decreases in cGMP.
L-3,4-dihydroxyphenylalanine
This article has been cited by other articles:
![]() |
V. A Fitsanakis, G. Piccola, A. P. Marreilha dos Santos, J. L Aschner, and M. Aschner Putative proteins involved in manganese transport across the blood-brain barr 1ier Human and Experimental Toxicology, April 1, 2007; 26(4): 295 - 302. [Abstract] [PDF] |
||||
![]() |
P. Soares-da-Silva and M. P. Serrao High- and low-affinity transport of L-leucine and L-DOPA by the hetero amino acid exchangers LAT1 and LAT2 in LLC-PK1 renal cells Am J Physiol Renal Physiol, August 1, 2004; 287(2): F252 - F261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pinho, P. Gomes, M. P. Serrao, M. J. Bonifacio, and P. Soares-da-Silva Organ-Specific Overexpression of Renal LAT2 and Enhanced Tubular L-DOPA Uptake Precede the Onset of Hypertension Hypertension, October 1, 2003; 42(4): 613 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ahlskog Slowing Parkinson's disease progression: Recent dopamine agonist trials Neurology, February 11, 2003; 60(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fraga, M. P. Serrao, and P. Soares-da-Silva L-Type Amino Acid Transporters in Two Intestinal Epithelial Cell Lines Function as Exchangers with Neutral Amino Acids J. Nutr., April 1, 2002; 132(4): 733 - 738. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |